Skip to content

Insider · CIK 0001800668

Jack Anders

cfoofficer

Files at RVMD (Revolution Medicines, Inc.). First filing Oct 15, 2024, latest Sep 18, 2026.

Jack Anders files SEC Form 4 as CFO at RVMD (Revolution Medicines, Inc.). Since Oct 15, 2024, Jack Anders has reported 0 open-market buys worth $0 and 14 open-market sells worth $8.4M, the latest filed on Sep 18, 2026.

A track record needs three past buys with six months of prices behind them; Jack Anders has 0, so none is measured yet.

The newest scored trade: sold $808k of RVMD on Sep 16, 2026, filed Sep 18, 2026, scored 39 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 8 sells worth $7.1M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $8.4M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RVMD: Revolution Medicines, Inc.

RVMDOct 9, 2026 · close 189.76

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
39Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$808k
4,053 shares
-3%+361% from low-11% from high
32Weak
RVMDsell 710b5-1
Revolution Medicines, Inc.
$3.4M
20,000 shares
-14%+389% from low0% from high
33Weak
RVMDsell 710b5-1
Revolution Medicines, Inc.
$425k
2,722 shares
-2%+351% from low-4% from high
30Weak
RVMDsell 810b5-1
Revolution Medicines, Inc.
$274k
2,753 shares
-2%+218% from low-20% from high
27Weak
RVMDsell 310b5-1
Revolution Medicines, Inc.
$980k
10,000 shares
-8%+230% from low0% from high
30Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$239k
3,104 shares
-3%+149% from low-3% from high
18Weak
RVMDsell 310b5-1
Revolution Medicines, Inc.
$401k
5,418 shares
-5%+145% from low0% from high
22Weak
RVMDsell 310b5-1
Revolution Medicines, Inc.
$640k
10,000 shares
-8%+106% from low0% from high
27Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$106k
2,320 shares
-2%+44% from low-26% from high
18Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$401k
10,000 shares
-8%+27% from low-35% from high
26Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$86k
2,170 shares
-2%+28% from low-34% from high
25Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$73k
1,864 shares
-2%+6% from low-35% from high
27Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$120k
2,635 shares
-3%-
20Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$503k
10,000 shares
-9%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 15, 2026 RVMD
Revolution Medicines, Inc.
3,939
0.00% of outstanding
$803kSep 15, 2026$3.8M
Jun 24, 2026 RVMD
Revolution Medicines, Inc.
20,000
0.01% of outstanding
$3.4MJun 24, 2026$425k
Jun 15, 2026 RVMD
Revolution Medicines, Inc.
2,653
0.00% of outstanding
$408kJun 15, 2026$274k
Mar 13, 2026 RVMD
Revolution Medicines, Inc.
2,134
0.00% of outstanding
$213kMar 16, 2026$1.2M
Jan 7, 2026 RVMD
Revolution Medicines, Inc.
10,000
0.01% of outstanding
$799kJan 7, 2026$1.3M
Dec 12, 2025 RVMD
Revolution Medicines, Inc.
3,017
0.00% of outstanding
$235kDec 15, 2025$1.1M
Nov 25, 2025 RVMD
REVOLUTION MEDICINES INC
5,418
0.00% of outstanding
$399kNov 25, 2025$1.1M
Nov 12, 2025 RVMD
REVOLUTION MEDICINES, INC.
10,000
0.01% of outstanding
$627kNov 11, 2025$507k
Sep 15, 2025 RVMD
Revolution Medicines, Inc.
2,128
0.00% of outstanding
$99kSep 15, 2025$487k
Sep 2, 2025 RVMD
REVOLUTION MEDICINES INC
10,000
0.01% of outstanding
$380kSep 2, 2025$86k
Jun 13, 2025 RVMD
Revolution Medicines, Inc.
2,127
0.00% of outstanding
$87kJun 16, 2025$73k
Mar 14, 2025 RVMD
Revolution Medicines, Inc.
2,108
0.00% of outstanding
$82kMar 17, 2025$120k
Dec 16, 2024 RVMD
Revolution Medicines, Inc.
2,600
0.00% of outstanding
$117kDec 16, 2024$602k
Oct 11, 2024 RVMD
Revolution Medicines, Inc
10,000
0.01% of outstanding
$495kOct 11, 2024none

Transactions

Every row this insider has filed, 41 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-61$195.00$12k123,20825 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,992$199.30$796k119,21625 d ago
Jun 24, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+20,000$18.56$371k143,269Jun 26, 2026
Jun 24, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,553$167.35$762k138,716Jun 26, 2026
Jun 24, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-9,496$168.20$1.6M129,220Jun 26, 2026
Jun 24, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,651$169.24$956k123,569Jun 26, 2026
Jun 24, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-300$170.32$51k123,269Jun 26, 2026
Jun 24, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
+20,000$0.00$020,600Jun 26, 2026
Jun 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,722$156.12$425k123,269Jun 18, 2026
Mar 17, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,753$99.48$274k125,512Mar 19, 2026
Mar 1, 2026RVMD
Revolution Medicines, Inc.
AGrant or award
Common Stock
+20,200$0.00$0128,265Mar 3, 2026
Mar 1, 2026RVMD
Revolution Medicines, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+45,400$0.00$045,400Mar 3, 2026
Jan 7, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+10,000$42.45$425k118,065Jan 9, 2026
Jan 7, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-10,000$98.00$980k108,065Jan 9, 2026
Jan 7, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-10,000$0.00$015,900Jan 9, 2026
Dec 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,104$77.09$239k108,065Dec 18, 2025
Nov 25, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+5,418$17.00$92k116,412Nov 26, 2025
Nov 25, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,418$74.00$401k110,994Nov 26, 2025
Nov 25, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-5,418$0.00$00Nov 26, 2025
Nov 11, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+10,000$17.00$170k120,994Nov 13, 2025
Nov 11, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-10,000$64.00$640k110,994Nov 13, 2025
Nov 11, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-10,000$0.00$05,418Nov 13, 2025
Sep 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,320$45.82$106k110,994Sep 18, 2025
Sep 2, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+2,814$2.68$7,542116,128Sep 4, 2025
Sep 2, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+1,948$4.73$9,214118,076Sep 4, 2025
Sep 2, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,762$40.02$191k113,314Sep 4, 2025
Sep 3, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+3,189$4.73$15k116,503Sep 4, 2025
Sep 3, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+2,049$17.00$35k118,552Sep 4, 2025
Sep 3, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,238$40.17$210k113,314Sep 4, 2025
Sep 2, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-2,814$0.00$00Sep 4, 2025
Sep 2, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,948$0.00$03,189Sep 4, 2025
Sep 3, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,189$0.00$00Sep 4, 2025
Sep 3, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-2,049$0.00$015,418Sep 4, 2025
Jun 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,170$39.83$86k113,314Jun 18, 2025
Mar 17, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,864$39.04$73k115,006Mar 19, 2025
Mar 1, 2025RVMD
Revolution Medicines, Inc.
AGrant or award
Common Stock
+20,400$0.00$0116,870Mar 4, 2025
Mar 1, 2025RVMD
Revolution Medicines, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+71,400$0.00$071,400Mar 4, 2025
Dec 16, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,635$45.40$120k96,470Dec 18, 2024
Oct 11, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+10,000$2.68$27k108,932Oct 15, 2024
Oct 11, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-10,000$50.30$503k98,932Oct 15, 2024
Oct 11, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-10,000$0.00$02,814Oct 15, 2024

Questions about Jack Anders

Answered from the filings on this page, as of the latest one.

Is Jack Anders buying or selling?

In the last 12 months Jack Anders reported 0 open-market buys worth $0 and 8 open-market sells worth $7.1M on SEC Form 4; the latest was sold $808k of RVMD on Sep 16, 2026. Grants, option exercises and tax withholding are not counted.

How did Jack Anders's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jack Anders has 0.

Where does Jack Anders file Form 4?

Jack Anders has filed Form 4 at RVMD (Revolution Medicines, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jack Anders: insider trades and track record | InsiderTell